Feld Michael has officially filed a Form 144 to report a proposed sale of securities. This filing, submitted on October 26, 2026, highlights significant developments that could impact the company's ownership structure and liquidity strategies.
Background
Feld Michael is categorized as an 'other' entity type with no specific SIC code or ticker symbols listed. The company has been active in filing with the SEC, with its most recent filings including multiple Form 144 and Form 4 submissions, demonstrating ongoing activity in the securities market.
What the Filing Says
The Form 144 filing indicates a proposed sale of securities, although specific details regarding the number of shares or the timing of the sale were not disclosed. The filing states, "Report of proposed sale of securities," without further elaboration.
Impact
This proposed sale may affect various stakeholders, including investors and market analysts, who will be closely monitoring the implications of this filing. Additionally, competitors in the surgical and medical instruments industry may respond to the changes in Feld Michael's ownership dynamics.
What's Next
The filing does not say what happens next, leaving uncertainty regarding the execution of the proposed sale or any subsequent actions that may follow.
Filer Information
The filing was submitted by Feld Michael, who is identified as a reporting entity with the Central Index Key (CIK) number 0002034349. The business address listed for Feld Michael is 1 Becton Drive, Franklin Lakes, NJ 07417.
Company Overview
Feld Michael is associated with Becton Dickinson & Co, which has a CIK number of 0000010795. The company operates within the surgical and medical instruments industry, specifically categorized under SIC code 3841. This classification indicates a focus on manufacturing surgical and medical instruments and apparatus.
Additional Filing Details
The Form 144 was accepted on the same day it was filed, October 26, 2026, at 16:28:02. The filing consists of one document, which is available in both HTML and XML formats, indicating a structured approach to compliance with SEC regulations.
Unspecified Aspects
The filing does not provide any specifics regarding the number of shares intended for sale, the price range, or the rationale behind the proposed sale. Additionally, there is no mention of any potential impact on the company's financial performance or strategic direction resulting from this sale.